Company insight Keeping the chain cold
When transporting temperature-sensitive products, every effort must be made to ensure that the entire logistics chain is kept on ice. The Opticooler active container from DoKaSch Temperature Solutions ensures a reliable cold chain through use of active temperature-controlled packaging solutions to guarantee pharmaceuticals arrive at the temperature they need to be.
I
n the ever-evolving pharmaceutical industry, the safeguarding of temperature-sensitive products during transportation is non-negotiable. Active containers play a crucial role in ensuring the secure and efficient delivery of life- saving medications to patients worldwide. A fundamental change has occurred with the appearance of active containers, and among these innovations, the Opticooler from DoKaSch Temperature Solutions. The pharmaceutical industry transports goods worth over a trillion dollars annually. The transportation of pharmaceuticals demands stringent processes in order to maintain the cold chain and preserve quality and effectiveness. Temperature-sensitive pharmaceuticals necessitate specialised packaging solutions, dedicated storage facilities, harmonised handling procedures and a committed collaboration among all stakeholders in the cold chain.
Keeping pharma on ice So, how can pharmaceuticals be safely transported without temperature fluctuations on intercontinental flights, given this complex task? The German company DoKaSch Temperature Solutions specialises precisely in this challenge. Since 2004, they have been developing the Opticooler, an active temperature-controlled high-end aircraft container designed for the transport of high-value, temperature-sensitive pharmaceuticals. Technical reliability, high availability and dependable service are the primary focus to ensure the effectiveness of these valuable medicines transported worldwide. The Opticooler RKN and RAP can cool and heat using electric compressors and heaters, enabling it to maintain a precise temperature range in any climate, specifically within -30 to +50 degrees, even for weeks if necessary. Andreas Seitz, managing director of DoKaSch Temperature Solutions, explains: “Even in the case of unforeseen events, such as a sudden change in transport route, active packaging solutions are considered
58
Due to its electric function, the Opticooler is not only a highly reliable transport solution, but can also be used as a warehouse when cool chain infrastructure is unavailable.
particularly suitable compared to passive solutions, as they keep their cargoes at a strict temperature level regardless the extreme external conditions that might occur during shipment.”
Active solutions like the Opticooler are also reusable and battery-powered, granting them almost unlimited runtime. Therefore, they can also serve as temporary storage units, an important aspect if transport takes longer or is delayed due to limited capacities. This makes them much more flexible and convenient compared to passive solutions.
Multiple redundancy systems Additionally, the Opticooler has global qualifications and approvals from pharmaceutical shippers for transcontinental transport across varying climate scenarios, preventing the need for repetitive, labour- intensive qualifications on different routes, as often required by passive units. The installation of multiple redundancy systems enhances technical safety and reliability and reinforces the company’s commitment to the safe transport of high-value pharmaceuticals. The Opticooler concentrates not only on maintaining temperature precision; it focuses
on reliability by mitigating risks associated with temperature fluctuations, by undergoing thorough preventive maintenance after each journey to ensure integrity is always maintained. As an integral part of the supply chain, DoKaSch Temperature Solutions focuses on maintaining depots in proximity to the production sites of high-value pharmaceuticals. DoKaSch TS already has strategically placed depots and employees in the US, Europe, South Korea, China, Japan, Israel and India. Combined with a free delivery network and partnerships with over 50 airlines, DoKaSch TS offers high availability, easy, fast, flexible and close access to the containers. Seitz adds: “We have already established an excellent presence in the most important markets for pharmaceutical production, with strategically located depots and representative offices. To flexibly meet future demand, we are already in the planning stages for additional depots and locations. Furthermore, we continuously expand our network through agreements with major airlines.” ●
www.dokasch-ts.com World Pharmaceutical Frontiers /
www.worldpharmaceuticals.net
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61
